SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$1.42
arrow_upward
+0.71%(+0.0100) 1D
$1.37
arrow_downward
-3.52% (-0.050)bedtimeAfter hours
Closed: Sep 30, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$1.36
High
$1.42
Low
$1.32
Mkt. cap
809.43K
Avg. vol.
2.39M
Volume
403.00
52-wk high
$16.30
52-wk low
$1.32
EPS
-$2.80
Beta
2.08
Shares outstanding
706.59K
No. of employees
45
Open
$1.36
High
$1.42
Low
$1.32
Mkt. cap
809.43K
Avg. vol.
2.39M
Volume
403.00
52-wk high
$16.30
52-wk low
$1.32
EPS
-$2.80
Beta
2.08
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
FXStreet
·
37 minutes ago
Dow Jones futures decline as markets weigh on rising US yields
The Motley Fool
·
33 minutes ago
If You'd Invested $10,000 in an S&P 500 ETF During the Last Bear Market, Here's How Much You'd Have Today
Reuters
·
53 minutes ago
Dow futures hit three-month low as yields surge, Micron earnings offer support
VT Markets
·
3 hours ago
Dow Jones (DJ30): Key Levels to Watch Before US Non-Farm Payrolls
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR